Neglected password? Login Carry on searching If you do not yet have an account, make sure you  make an account make an account favouriteItem.successMessage information In July 2016, MDMB-CHMICA was the 1st synthetic cannabinoid receptor agonist to get risk-assessed because of the EMCDDA (35) and it's got not too long ago been subjected to control